Investor's Business Daily on MSN1h
Novo Nordisk Slips On Analyst Warning Of Weaker Wegovy Sales
Novo Nordisk stock fell after a JPMorgan analyst said sales of its blockbuster weight-loss drug may be weaker-than-expected.
Novo Nordisk Just Committed More Than $1.1 Billion to Make the Next Ozempic, but Is the Stock a Buy?
In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...
European Stocks Close Higher On Hopes Of More Chinese Stimulus, Further Rate Cuts
European stocks closed higher on Thursday amid optimism the Chinese government will announce more stimulus measures to help spur ...
Evotec and Novo Nordisk in technology development partnership
German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk to support ...
MT Newswires on MSN23h
European Equities Close Higher Thursday; Luxury Goods, Mining Stocks Rally on China Stimulus Package
The European stock markets closed higher on Thursday as the Stoxx Europe 600 rose 1.19%, the Swiss Market Index gained 0.50%, France's CAC climbed 2.33%, the FTSE in London was up 0.20%, and Germany's ...